ACE2 News and Research

RSS
Latest tools for COVID-19 Omicron variant research

Latest tools for COVID-19 Omicron variant research

Optimal monoclonal antibodies against SARS-CoV-2 variants

Optimal monoclonal antibodies against SARS-CoV-2 variants

SARS-CoV-2 activates microglia in the brain

SARS-CoV-2 activates microglia in the brain

SARS-CoV-2 Omicron variant's infectivity, vaccine breakthrough, and antibody resistance

SARS-CoV-2 Omicron variant's infectivity, vaccine breakthrough, and antibody resistance

SARS-CoV-2 shown to spread through cell-to-cell transmission

SARS-CoV-2 shown to spread through cell-to-cell transmission

SARS-CoV-2 spike engagement of ACE2 shown to prime S2′ site cleavage and fusion initiation

SARS-CoV-2 spike engagement of ACE2 shown to prime S2′ site cleavage and fusion initiation

Researchers plan to review the effect of SARS-CoV-2 on male reproductive health

Researchers plan to review the effect of SARS-CoV-2 on male reproductive health

Engineered small extracellular vesicles for the neutralization of SARS-CoV-2

Engineered small extracellular vesicles for the neutralization of SARS-CoV-2

SARS-CoV-2 Omicron variant uses endosomal entry pathway and grows in upper respiratory tract cells

SARS-CoV-2 Omicron variant uses endosomal entry pathway and grows in upper respiratory tract cells

Emerging SARS-CoV-2 B.1.619 and B.1.620 variants in South Korea

Emerging SARS-CoV-2 B.1.619 and B.1.620 variants in South Korea

Lab engineered human A549 lung cell model conducive for investigating SARS-CoV-2 antivirals

Lab engineered human A549 lung cell model conducive for investigating SARS-CoV-2 antivirals

SARS-CoV-2 Omicron a product of offensive evolution with compromised antigenicity

SARS-CoV-2 Omicron a product of offensive evolution with compromised antigenicity

Dual-receptors help widespread dissemination of SARS-CoV-2

Dual-receptors help widespread dissemination of SARS-CoV-2

Scientists discover antibody that inhibits a broad range of sarbecoviruses

Scientists discover antibody that inhibits a broad range of sarbecoviruses

SARS-CoV-2 Omicron variant leads to widespread escape from neutralizing antibody responses

SARS-CoV-2 Omicron variant leads to widespread escape from neutralizing antibody responses

Researchers isolate Omicron variant, leveling the path to vaccine development and vaccine efficacy studies

Researchers isolate Omicron variant, leveling the path to vaccine development and vaccine efficacy studies

From laboratory to clinic - Nanotechnology-enabled mRNA COVID-19 vaccines

From laboratory to clinic - Nanotechnology-enabled mRNA COVID-19 vaccines

Antibody binding response significantly reduced for Omicron compared to other SARS-CoV-2 variants

Antibody binding response significantly reduced for Omicron compared to other SARS-CoV-2 variants

Researchers outline characteristics of Omicron variant immune escape and viral entry into host cells

Researchers outline characteristics of Omicron variant immune escape and viral entry into host cells

Small molecule identified as a SARS-CoV-2 inhibitor

Small molecule identified as a SARS-CoV-2 inhibitor